Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed) (RFA AG 20 014)
Opportunity Information:
- The Department of Health and Human Services, National Institutes of Health in the health sector is offering a public funding opportunity titled "Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on Mar 05, 2019.
- Applicants must submit their applications by Jul 02, 2019.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Browse more opportunities from the same category: Health
Next opportunity: Fish and Wildlife Management Assistance
Previous opportunity: Research and Evaluation on Trafficking in Persons, FY 2019
Grant Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 014) also looked into and applied for these:
| Funding Number | Funding Title |
| HRSA 19 097 | Newborn Screening State Evaluation Program |
| TI 19 004 | First Responders-Comprehensive Addiction and Recovery Act |
| HRSA 19 082 | Rural Communities Opioid Response Program-Implementation |
| HRSA 19 083 | Rural Communities Opioid Response Program-Evaluation |
| PA FPR 19 002 | Announcement of Availability of Funds for Data Analysis and Trends Research Grants |
| AID RFI 663 19 00002 | Eliminate Tuberculosis in Ethiopia (ETBE) |
| CDC RFA DP19 1903 | Good Health and Wellness in Indian Country |
| HRSA 19 002 | Graduate Psychology Education (GPE) Program |
| HRSA 19 089 | Opioid Workforce Expansion Program (OWEP) Paraprofessionals |
| HRSA 19 085 | Opioid Workforce Expansion Program (OWEP) Professionals |
| RFA HL 20 003 | Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional) |
| RFA HL 20 004 | Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) |
| RFA DE 19 010 | Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed) |
| RFA HL 20 010 | BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allow |
| RFA HL 20 009 | BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional) |
| 72067419RFA00005 | Karabo ea Bophelo (KB) Activity in Lesotho |
| PA EAA 19 001 | Announcement of Availability of Funds for Embryo Adoption/Donation Services and Public Awareness Grants |
| RFA AI 19 014 | Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required |
| SM 19 011 | Transforming Lives Through Supported Employment |
| TI 19 009 | National Evaluation of the Technology Transfer Center Program |
Grant Application Guides and Resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 014", eligibility, application service, and/or application tips? Submit an inquiry below:
Ask a Question:
Application Process
Step 1
Self assessment. Grants are available to government, education, public housing, and not for profit organizations. If you are a small business, your business must exceed SBA's size standards.
Step 2
Review the funding details for the opportunity (RFA AG 20 014) and check/verify your eligibility.
Step 3
Register as an individual or as an organization and obtain your grants.gov account.
Step 4
Prepare your application package. Utilize grants.gov's workspace collaboration feature if needed. Submit your application and obtain your unique tracking number.
Step 5
Funding officials will review your application package. Use your tracking number to view and check on the status of your application.